Broward County Commission Regular Meeting
Director's Name: Andrew J. Meyers
Department: County Attorney
Information
Requested Action
title
MOTION TO APPROVE Participation Agreement regarding opioid litigation in substantially the same form as Exhibit 1; and to authorize the County Administrator to execute the Participation Agreement with any required modifications; provided such modifications do not impose any additional material financial risk on the County, and subject to review and approval as to legal sufficiency by the County Attorney's Office.
body
Why Action is Necessary
Approval is required by the Board of County Commissioners ("Board") to resolve the County's pre-suit claims against Alvogen, Inc., Amneal Pharmaceuticals, Inc., Apotex, Inc., Hikma Pharmaceuticals USA, Inc., Indivior, Inc., Mylan Pharmaceuticals, Inc., Sun Pharmaceutical Industries, Inc., and Zylus Pharmaceuticals, Inc., eight manufacturers of opioid drugs, collectively referred to as the "Defendants."
What Action Accomplishes
Allows the Board to approve the Participation Agreement, which will settle and release any of the County's potential opioid claims against the eight manufacturers of opioid drugs.
Goal Related Icon(s)
?County Commission
?Go Green
?MAP Broward
Previous Action Taken
Summary Explanation/Background
On September 21, 2021, the Board adopted Resolution No. 2021-464 (Item No. 51), which approved the Florida Opioid Allocation and Statewide Response Agreement (the "Florida Plan"). The Florida Plan provided the framework to resolve the pending claims against opioid drug distributors, manufacturers, marketers, and other potential parties in connection with the opioid epidemic. The material provisions of the Florida Plan provide that: (1) the Florida Attorney General is authorized to negotiate and enter into settlements with the defendants in the multidistrict opioid litigation on behalf of Florida's subdivisions and cities; (2) the settlement proceeds ...
Click here for full text